Carole Ben-Maimon insider trades

Open-market stock purchases and sales by Carole Ben-Maimon, President and CEO at Larimar Therapeutics, Inc, from SEC Form 4 filings since Oct 28, 2011.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -7%.

Recent trades

DateStockTradeValue
Jan 26, 2026LRMR Larimar Therapeutics, IncBought (not open market)—
Jan 26, 2026LRMR Larimar Therapeutics, IncBought (not open market)—

Companies traded

  • LRMR Larimar Therapeutics, Inc: 2 buys, last Jan 26, 2026
  • TLGT Teligent, Inc: 3 buys, last Jul 21, 2021
  • IPXL Impax Laboratories Inc: other filings, last May 14, 2014

Get free alerts when Carole Ben-Maimon files a new trade →